Yoon, Hyunho
Tang, Chih-Min
Banerjee, Sudeep
Yebra, Mayra
Noh, Sangkyu
Burgoyne, Adam M.
Torre, Jorge De la
Siena, Martina De http://orcid.org/0000-0003-4913-7254
Liu, Mengyuan
Klug, Lillian R.
Choi, Yoon Young
Hosseini, Mojgan
Delgado, Antonio L.
Wang, Zhiyong
French, Randall P.
Lowy, Andrew
DeMatteo, Ronald P.
Heinrich, Michael C. http://orcid.org/0000-0003-3790-0478
Molinolo, Alfredo A.
Gutkind, J. Silvio
Harismendy, Olivier
Sicklick, Jason K. http://orcid.org/0000-0003-4403-0271
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 CA226803)
Article History
Received: 24 August 2020
Revised: 13 January 2021
Accepted: 27 January 2021
First Online: 18 February 2021
Compliance with ethical standards
:
: JKS receives research funds from Foundation Medicine Inc. and Novartis Pharmaceuticals, as well as consultant fees from Deciphera, Loxo, Biotheranostics, and Grand Rounds. MCH: Consultant: Deciphera Pharmaceuticals, Blueprint Medicines, Novartis, Molecular MD; Patent licensing: Novartis; Research funding: Deciphera Pharmaceuticals, Blueprint Medicines; Equity interest: Molecular MD.